drugset / Trial / NCT05370729

Impact of N-acetylcysteine Infusion and Intralipid Infusion on Myocardial Injury in Aluminum Phosphide Toxicity

NCT05370729

Unknown 58 enrolled Assiut University
RandomizedParallel-groupDouble-blindTreatment

Summary

Assess impact of ILE and NAC in morbidity and mortality when used as adjuvant therapy to routine management of acute ALP poisoning.

Timeline

Start
2022-05
Primary completion
2024-05
Completion
2025-05

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule 100 mg/kg Intravenous

Indications

No indication recorded.